Webinar: See the New Features of Neurolucida 360 2020.3.1
October 7th, 2020
Join MBF Bioscience's Scientific Director, Dr. Susan Tappan, and Labs Analyst, TJ Tetreault, for a comprehensive demonstration of the latest capabilities of Neurolucida 360 and how they can benefit your research. Please join us as they cover many new features such as puncta detection, generating and reconstructing within subvolumes, as well as the other vast computational improvements regarding image and data performance.
Automatic 3D Neuron Reconstruction and Quantitative Analysis
Neurolucida 360 version 2020 includes many new and improved capabilities designed to both speed up your research and provide novel tools for discovery. This release contains significant enhancements, including intelligent image handling of big data and machine learning. Our continuous process of making software improvements, combined with our rigorous quality control processes, help ensure that MBF software is state-of-the-art, robust and reliable.
The NIH Showcases MBF Bioscience Successes
|We are proud to be included among the 50 innovative companies across the US who are named by the NIH as Small Business Success Stories. As a multiple-time recipient of Small Business Innovation Research (SBIR) grant awards, MBF Bioscience owes deep gratitude to the NIH. Since our founding in 1987, our team has taken pride in our drive and devotion to continually advancing our products and providing cutting-edge technology to researchers in over 1,500 labs in 44 countries. Achievements like this make the effort truly worthwhile. Thank you to the NIH for listing MBF Bioscience as one of your 50 Small Business Success Stories.|